Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Taro Pharmaceutical Industries stock | $64.83

Learn how to easily invest in Taro Pharmaceutical Industries stock.

Taro Pharmaceutical Industries Ltd is a drug manufacturers-specialty & generic business based in the US. Taro Pharmaceutical Industries shares (TARO) are listed on the NYSE and all prices are listed in US Dollars. Taro Pharmaceutical Industries employs 1,417 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Taro Pharmaceutical Industries

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TARO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Taro Pharmaceutical Industries stock price (NYSE: TARO)

Use our graph to track the performance of TARO stocks over time.

Taro Pharmaceutical Industries shares at a glance

Information last updated 2021-09-12.
Latest market close$64.83
52-week range$53.95 - $80.00
50-day moving average $70.29
200-day moving average $72.75
Wall St. target price$82.00
PE ratio 90.1425
Dividend yield N/A (13.23%)
Earnings per share (TTM) $0.77

Buy Taro Pharmaceutical Industries shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
Get two free stocks valued between $3.00 and $300 with a deposit to any new account.
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Taro Pharmaceutical Industries stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Taro Pharmaceutical Industries price performance over time

Historical closes compared with the close of $64.83 from 2021-09-17

1 week (2021-09-10) -6.84%
1 month (2021-08-18) -5.58%
3 months (2021-06-18) -11.28%
6 months (2021-03-19) -15.04%
1 year (2020-09-18) 11.78%
2 years (2019-09-18) -20.68%
3 years (2018-09-18) 98.73
5 years (2016-09-16) 117.59

Is Taro Pharmaceutical Industries under- or over-valued?

Valuing Taro Pharmaceutical Industries stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Taro Pharmaceutical Industries's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Taro Pharmaceutical Industries's P/E ratio

Taro Pharmaceutical Industries's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 90x. In other words, Taro Pharmaceutical Industries shares trade at around 90x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Taro Pharmaceutical Industries's EBITDA

Taro Pharmaceutical Industries's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $180.6 million.

The EBITDA is a measure of a Taro Pharmaceutical Industries's overall financial performance and is widely used to measure a its profitability.

Taro Pharmaceutical Industries financials

Revenue TTM $578.4 million
Operating margin TTM 27%
Gross profit TTM $296.7 million
Return on assets TTM 4.07%
Return on equity TTM 1.83%
Profit margin 5.1%
Book value $43.87
Market capitalisation $2.6 billion

TTM: trailing 12 months

Shorting Taro Pharmaceutical Industries shares

There are currently 123,494 Taro Pharmaceutical Industries shares held short by investors – that's known as Taro Pharmaceutical Industries's "short interest". This figure is 2.3% up from 120,761 last month.

There are a few different ways that this level of interest in shorting Taro Pharmaceutical Industries shares can be evaluated.

Taro Pharmaceutical Industries's "short interest ratio" (SIR)

Taro Pharmaceutical Industries's "short interest ratio" (SIR) is the quantity of Taro Pharmaceutical Industries shares currently shorted divided by the average quantity of Taro Pharmaceutical Industries shares traded daily (recently around 21074.061433447). Taro Pharmaceutical Industries's SIR currently stands at 5.86. In other words for every 100,000 Taro Pharmaceutical Industries shares traded daily on the market, roughly 5860 shares are currently held short.

However Taro Pharmaceutical Industries's short interest can also be evaluated against the total number of Taro Pharmaceutical Industries shares, or, against the total number of tradable Taro Pharmaceutical Industries shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Taro Pharmaceutical Industries's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Taro Pharmaceutical Industries shares in existence, roughly 0 shares are currently held short) or 0.0149% of the tradable shares (for every 100,000 tradable Taro Pharmaceutical Industries shares, roughly 15 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Taro Pharmaceutical Industries.

Find out more about how you can short Taro Pharmaceutical Industries stock.

Taro Pharmaceutical Industries share dividends

We're not expecting Taro Pharmaceutical Industries to pay a dividend over the next 12 months.

Have Taro Pharmaceutical Industries's shares ever split?

Taro Pharmaceutical Industries's shares were split on a 2:1 basis on 26 July 2001. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Taro Pharmaceutical Industries shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Taro Pharmaceutical Industries shares which in turn could have impacted Taro Pharmaceutical Industries's share price.

Taro Pharmaceutical Industries share price volatility

Over the last 12 months, Taro Pharmaceutical Industries's shares have ranged in value from as little as $53.95 up to $80. A popular way to gauge a stock's volatility is its "beta".

TARO.US volatility(beta: 1.04)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Taro Pharmaceutical Industries's is 1.0409. This would suggest that Taro Pharmaceutical Industries's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Taro Pharmaceutical Industries overview

Taro Pharmaceutical Industries Ltd. , a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprises allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel.

Stocks similar to Taro Pharmaceutical Industries

Frequently asked questions

What percentage of Taro Pharmaceutical Industries is owned by insiders or institutions?
Currently 77.777% of Taro Pharmaceutical Industries shares are held by insiders and 13.253% by institutions.
How many people work for Taro Pharmaceutical Industries?
Latest data suggests 1,417 work at Taro Pharmaceutical Industries.
When does the fiscal year end for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries's fiscal year ends in March.
Where is Taro Pharmaceutical Industries based?
Taro Pharmaceutical Industries's address is: 14 Hakitor Street, Haifa, Israel, 2624761
What is Taro Pharmaceutical Industries's ISIN number?
Taro Pharmaceutical Industries's international securities identification number is: IL0010827181
What is Taro Pharmaceutical Industries's CUSIP number?
Taro Pharmaceutical Industries's Committee on Uniform Securities Identification Procedures number is: M8737E108

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site